MIR6133

Across TCGA pan-cancer cohorts, MIR6133 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR6133 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MIR6133 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6133 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.

COAD, CESC, and THCA are the cancer types where MIR6133 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	III,IV	0.141	0.800	<.001	72	view →
CESC	OS	Tertile	II,III,IV	0.124	0.759	<.001	72	view →
THCA	OS	Tertile	IV	0.626	1.000	.002	45	view →
SKCM	OS	Tertile	IV	0.179	0.755	<.001	42	view →
OV	DFS	Tertile	III,IV	0.381	0.541	.011	36	view →
ESCA	OS	Tertile	III,IV	0.788	0.355	.015	24	view →
LUAD	DFS	Tertile	All	0.947	0.655	.021	24	view →
LGG	DFS	Tertile	All	0.256	0.763	<.001	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR6133–COAD (OS)

Open the COAD breakdown →